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Recent studies are revealing astonishing heterogeneity in host-pathogen interactions occurring simulta-
neously within the same host tissue. As highlighted in this review, growing knowledge of the in vivo
complexity is altering our understanding of infection biology. In particular, pathogen subsets reside in diverse
tissuemicroenvironments and detect and respond to local conditions. The individual pathogen-host encoun-
ters have disparate outcomes, depending on differential molecular interactions. As a result, disease progres-
sion can result from failure to control individual infection foci, despite successful eradication of others,
and antibiotic therapy can be delayed by distinct pre-existing pathogen subsets. Together, these data are
unraveling rich biology with implications for infectious disease progression and control.Introduction
Infectious diseases are amajor health problemworldwide. Infec-
tions usually start with just a few pathogen cells penetrating
body surfaces, but disease signs appear only later, when the
pathogen grows to high tissue loads. Pathogen growth and
counterdefenses by the host immune system occur in host tis-
sues with complex anatomy, diverse cell types, and biochemi-
cally and physically distinct microenvironments. This rich biology
could significantly impact the outcomes of local host-pathogen
encounters, overall disease progression, and antimicrobial
treatment.
Nevertheless, this tissue complexity has been largely ignored
in infection research. In vivo analysis commonly starts with tissue
homogenization that destroys the topology, and bulk average
readouts disregard heterogeneity among cell populations.
In vitro cell culture infection models typically employ a single
host cell type and thus fail to mimic the complex in vivo situation.
Only recently have methods including fluorescent reporters,
advanced live imaging, and separation of pathogen subsets
been developed to investigate individual encounters between
pathogen and host cells in situ in infected tissues. The emerging
results reveal the crucial importance of disparate host-pathogen
interactions that occur simultaneously within distinct micro-
environments in the same tissue (Figure 1).
The Diverse Landscape of Infected Host Tissues
Over many decades, histological analysis has revealed complex
microanatomies of tissues in various infectious diseases. Host
tissues are organized in compartments with distinct cellular
composition and physiology, such as white and red pulp in
spleen, or cortex and medulla of kidneys. In addition to this
intrinsic anatomical and physiological complexity, infection and
host immune responses enhance the diversity of tissue microen-
vironments. Infected tissues usually harbor distinct infection foci
with high pathogen densities. Around these foci, multiple inflam-
matory host cells accumulate and form inflammatory lesions.
Often, such lesions effectively eliminate infection foci and
resolve. In other cases, lesionsmaymature into highly structured
granulomas that can further progress into necrotic lesions, oreliminate infection and heal. Within and around lesions, host
immune effector mechanisms can result in substantial collateral
tissue damage. From established infection foci, many pathogens
disseminate to other tissue sites where they continuously found
new foci. This results in the coexistence of foci with different age
and size, and a corresponding diversity of inflammatory lesion
types.
One particularly well-studied example is tuberculosis (TB)
(Barry et al., 2009; Lin et al., 2009; Mattila et al., 2013). Lungs in-
fected with Mycobacterium tuberculosis contain a large variety
of coexisting lesion types, including (1) solid cellular granulomas
of densely packed macrophages; (2) necrotic granulomas with
an outer ring of T and B lymphocytes, a middle region containing
epithelioid and syncytialized macrophages (giant cells), and an
amorphous center of caseous necrosis; (3) open liquefied
cavities in which the caseous mass has direct access to the
bronchial airways (cavitary TB); (4) suppurative granulomas
with a large number of neutrophils; (5) fibrotic/fibrocalcific
lesions containing fibroblasts, collagen, and mineralization;
and (6) tuberculous pneumonia with extensive coalescing areas
of direct parenchymal infiltration and consolidation.
In addition to these lesion types, there is pronounced hetero-
geneity between individual lesions, and even within a single
lesion host activities may be inhomogeneous. This includes
host metabolism, expression of antimicrobial effector mecha-
nisms such as nitric oxide synthases (NOS), immune cell fre-
quencies and activation status, lipid content and composition,
and oxygen tension (Kim et al., 2010; Lin et al., 2013; Mattila
et al., 2013; Via et al., 2008). Moreover, lesion properties appear
to be highly dynamic, with changing size and metabolic activity
and transition between lesion types, as demonstrated by
serial 2-deoxy-2-[18F]-fluoro-D-glucose (FDG) positron emis-
sion tomography (PET) and computed tomography (CT) imaging
(Bobrowitz, 1980; Lin et al., 2013, 2014).
This type of complex tissue landscape also occurs in many
other infectious diseases. As an example, infection by host-
adapted Salmonella strains induces various lesions types in the
spleen, liver, and lymph nodes, including gut-associated Peyer’s
patches (Burton et al., 2014; Dougan et al., 2011). This includesCell Host & Microbe 17, January 14, 2015 ª2015 Elsevier Inc. 13
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Figure 1. Overview of Disparate Pathogen Encounters in Complex Host Tissues and Their Consequences
(A–D) Pathogen populations with stochastically varying phenotypes enter various microenvironments in infected host tissues. Overwhelming antimicrobial host
factors (ROS, reactive oxygen species; RNS, reactive nitrogen species; low pH; and other unknown mechanisms) kill pathogens during encounters in micro-
environment A, while permissive host conditions such as abundant nutrient and oxygen supply, together with still unknown factors, support vigorous pathogen
growth in microenvironment D. Intermediate conditions in microenvironments B and C enable pathogen survival and no (B) or moderate (C) pathogen growth.
Pathogen subsets emerging from the various encounters spread within and across organs and enter again diverse host environments. During antibiotic treat-
ment, nongrowing pathogen subsets initially survive while fast-growing subsets are largely killed. Moderately growing pathogen cells partially tolerate antibiotic
exposure and might dominate among surviving pathogens.
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surrounded by inflammatory monocytes, and a structured gran-
uloma with an outer ring of T and B lymphocytes. In addition,
Salmonella infection foci also emerge in not-yet-inflamed tissue
regions. At advanced disease stages, heavily inflamed Peyer’s
patches can burst open, causing life-threatening gut perforation.
As another example, Shigella infection causes massive neutro-
phil infiltration into the colon mucosa (Phalipon and Sansonetti,
2007). Collateral damage disrupts the gut epithelial barrier,
causing bleeding and free access for lumenal microbes to
mucosal tissues. In addition, neutrophils massively migrate into
the gut lumen at certain sites. Finally, Staphylococcus aureus
can cause structured abscesses consisting of a core of pus
encircled by a fibrin wall and accumulating inflammatory host
cells in multiple tissues, including the skin, heart valves, lung,
and bones (Lowy, 1998). From even small abscesses, Staphylo-
coccus can disseminate hematogenously. In addition, some
strains can cause severe tissue necrosis (Gordon and Lowy,
2008).
Consequences for Infectious Disease Progression and
Control?
Do these complex landscapes of infected tissues matter for
disease progression and control? This seems quite plausible,14 Cell Host & Microbe 17, January 14, 2015 ª2015 Elsevier Inc.although until recently clear experimental evidence has been
largely lacking. The enormous diversity of microenvironments
is likely to provide highly heterogeneous conditions for patho-
gens. This includes nutrient access; stress conditions such as
acidic pH, low oxygen availability, or high levels of reactive oxy-
gen and nitrogen species; direct exposure to attacking innate
and adaptive immune cells; and opportunities for dissemination
and transmission to new hosts. In some microenvironments, the
host might be able to kill pathogens, whereas in other microen-
vironments pathogens might survive and even replicate. Indeed,
divergent fates of individual pathogen cells in host tissues
were proposed in the late 1950s based on population dynamics
data for Salmonella infections (Meynell and Stocker, 1957). This
was later confirmed and extended using methods with higher
resolution (Grant et al., 2008; Sheppard et al., 2003).
Host sites where pathogens survive might provide divergent
conditions that affect pathogen growth and trigger specific ad-
aptations in local pathogen subsets. Such diverse environmental
conditions could thus greatly enhance pathogen heterogeneity,
in addition to the phenotypic variation between individual cells
that is caused by endogenous stochastic fluctuations in gene
expression as well as bacteria-bacteria interactions such as
quorum sensing and metabolic exchanges (Hammer et al.,
2014).
Cell Host & Microbe
MinireviewDiverse host microenvironments could also have a major
impact on antimicrobial chemotherapy. Drug distribution in tis-
sue can be strikingly inhomogeneous because of variable pene-
tration of antibiotic into infection foci and local differences in pH
and protein binding (Wagner et al., 2006). In addition, heteroge-
neous pathogen growth rates and differential stress exposure
can have a major impact on drug sensitivity (Balaban et al.,
2013), and antimicrobial host effector mechanisms involving
oxidative damage can cause distinct mutations that mediate
antimicrobial resistance in in local subsets (Ford et al., 2011;
Kaplan et al., 2003). Indeed, early evidence suggested that
during chemotherapy of active TB, ‘‘open cavities’’ (direct ac-
cess to bronchial airways) are dominated by Mycobacterium
tuberculosis subsets that have acquired resistance mutations,
whereas nonresistant subpopulations can survive in ‘‘closed
cavities’’ (no access to bronchial airways) (Vandiviere et al.,
1956).
However, conclusive experimental evidence for an impact of
complex host tissue microenvironments on infectious disease
progression is still largely lacking. In particular, five key questions
need to be addressed: (1) Are pathogens actually exposed to the
diverse host microenvironments, or do most pathogen cells
reside in a single type of microenvironment? (2) Do pathogens
respond to the diverse environments? (3) Are there divergent
outcomes of individual host-pathogen encounters depending
on the type of microenvironment? (4) Are some encounters
and their outcomes particularly important for overall disease pro-
gression? (5) Does antimicrobial chemotherapy efficacy vary for
pathogen subsets in different microenvironments?
Answering these questions requires a combination of well-
established histology and immunohistochemistry methods with
more recent approaches for analyzing pathogen properties at
the single-cell level. The following sections discuss approaches
and results for a few instructive cases. Overall, these emerging
data provide positive answers for all five questions, unravel
rich but still largely unexplored infection biology, and demon-
strate the major importance of pathogen heterogeneity in host
tissues for understanding host-pathogen interactions and their
impact on disease and treatment.
Pathogen Distribution in Distinct Tissue
Microenvironments
Quantitative studies that show in which host microenvironment
pathogens reside are surprisingly scarce. Again, one particularly
well-studied case is tuberculosis (Barry et al., 2009; Eum et al.,
2010; Fenhalls et al., 2002; Lin et al., 2009, 2014). Mycobacte-
rium tuberculosis is particularly abundant in open liquefied cav-
ities (in case of active disease), but can also be found in all other
granuloma types as well as apparently normal tissue areas.
Within granulomas, mycobacteria reside in diverse locations in
macrophages, giant cells, and neutrophils, as well as extracellu-
larly in the caseum.
As another example, Salmonella reside within neutrophils and
inflammatory monocytes in inflammatory lesions, as well as
within resident macrophages in apparently normal tissue regions
during systemic infection (Burton et al., 2014), and in the intesti-
nal lumen, in Peyer’s patches, and in the normal mucosa in
epithelial cells and lamina propria macrophages during enteritis
(Laughlin et al., 2014; Sellin et al., 2014).Additional examples include Shigella that resides in the
gut lumen, in the epithelium, in the underlying mucosa, and in
Peyer’s patches (Phalipon and Sansonetti, 2007);Vibrio cholerae
that resides both in the gut lumen and attached to the intestinal
epithelium (Nielsen et al., 2010); and Streptococcus pneumoniae
that resides in the airway mucus, attaches to epithelial cells, traf-
fics across those cells, and reaches the bloodstream during
lobular pneumonia. All this happens in increasingly inflamed
lungs with heavy infiltration by neutrophils (Henriques-Normark
and Tuomanen, 2013).
Together, the available data demonstrate that pathogens can
reside in a large variety of microenvironments within a single
infected host tissue. On the other hand, for most infectious
diseases, quantitative data are still largely lacking.
Pathogen Responses to Diverse Host
Microenvironments
Do pathogens detect, and respond to, the diverse microenviron-
ments in which they reside? If this is the case, we should be able
to detect pathogen subsets with different properties that map to
specific microenvironment types.
Gene expression of individual genes can be used to differen-
tiate such pathogen subsets. As an example, several transcripts
are differentially abundant in Mycobacterium residing in distinct
lesion types and various positions within necrotic granulomas,
which may suggest alternativeMycobacterium metabolic states
in these various microenvironments (Fenhalls et al., 2002). As
another example, Staphylococcus aureus expresses the major
virulence factor staphylocoagulase specifically at the outer
edge of abscesses during endocarditis (Panizzi et al., 2011).
Gene expression can be also studied using transcriptional
fusions of various promoters to fluorescent reporter genes.
Fusion activity of thousands of pathogen cells in tissue homog-
enates can be rapidly and accurately measured at the single-
cell level using flow cytometry. This technique has been used
to demonstrate highly heterogeneous expression of Salmonella
and Vibrio genes during intestinal infection (Laughlin et al., 2014;
Nielsen et al., 2010), Salmonella and Yersinia in the spleen (Bur-
ton et al., 2014; Davis et al., 2015), and Mycobacterium in the
lung (Tan et al., 2013). In several of these cases, cells with
high promoter activities could be mapped to specific tissue
microenvironments, suggesting a major impact of local host
conditions.
What are the environmental stimuli that pathogens detect and
respond to? In some cases, potential in vivo-inducing conditions
might be postulated based on in vitro promoter responses to
various stimuli. However, most promoters respond to multiple
stimuli in a context-dependent manner, and fusion constructs
might show distorted regulation compared to native transcrip-
tion units. To confirm potential inducing host signals, mousemu-
tants with specific molecular defects are useful. As an example,
mice deficient for inducible nitric oxide synthase (iNOS), or
functional NADPH oxidase, were used to demonstrate specific
Salmonella transcriptional responses to host nitric oxide (NO)
in tissue regions with dense infiltration by iNOS-expressing
inflammatory monocytes, or reactive oxygen species (ROS) in
disparate microenvironments (Burton et al., 2014). As another
example, promoter activity for the Yersinia NO-detoxification
gene hmp is low in the center of microcolonies in spleen butCell Host & Microbe 17, January 14, 2015 ª2015 Elsevier Inc. 15
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tive stress. Interestingly, a Yersinia hmpmutant has rather homo-
geneous promoter activities throughout the microcolonies,
suggesting that peripheral Yersinia actually protect the center
by local detoxification of external reactive nitrogen species
(RNS) (Davis et al., 2015).
Transcriptional fusions provide information on activities of one
particular promoter in single pathogen cells (or up to three pro-
moters when combining several colors). To obtain more compre-
hensive expression patterns, differentially fluorescent pathogen
subsets can be purified from tissues using flow cytometry and
analyzed by proteomics (Burton et al., 2014). This technique
was used to demonstrate that Salmonella respond to host-
generated nitrosative stress with local upregulation of just three
proteins, while Salmonella exposed to oxidative bursts show
more complex responses to oxidative damage and potentially
other stresses. Alternatively, pathogens can be isolated directly
from distinct microenvironments and analyzed by transcriptom-
ics, as shown for Vibrio cholerae from lumenal contents versus
intestinal epithelium/mucus (Nielsen et al., 2010).
Together, these studies show that various pathogens detect,
and specifically respond to, distinct microenvironments within
a single complex host tissue.
Divergent Outcomes of Individual Host-Pathogen
Encounters
In some cases, such pathogen responses can be fully adequate
to deal with stress conditions in the respective microenviron-
ment. As an example, local Salmonella detoxification of high
NO levels in some tissue regions reduces nitrosative stress to
noninhibiting levels (Burton et al., 2014). In other cases, however,
pathogen adaptation might be insufficient to fully compensate
for all host stresses, resulting in host-pathogen encounters
with divergent outcomes.
A recent study shows that in the monkey tuberculosis model,
many granulomas can eradicate local Mycobacterium tubercu-
losis populations (Lin et al., 2014). Interestingly, such successful
sterile granulomas are present even in monkeys with active
disease, where at the same time other Mycobacterium subsets
in open cavities vigorously proliferate. Similarly, inflammatory
lesions in infected spleen eradicate local Salmonella subsets,
although Salmonella in other infection foci in the same organ
rapidly proliferate, and mice succumb to infection within a few
days in this model (Burton et al., 2014). Within inflammatory le-
sions, neutrophils and inflammatory monocytes kill Salmonella
with ROS, whereas outside of these lesions, macrophages use
less effective, alternative killing mechanisms that require activa-
tion by IFNg. These findings demonstrate that progressive
infection is not necessarily the result of a general host inability
to control the pathogen. Instead, there are local successes and
failures as a result of distinct molecular and cellular interactions,
and only the net result of all these disparate encounters deter-
mines overall disease progression.
Pathogen subsets that manage to survive host immune at-
tacks still encounter microenvironments that might be more or
less permissive for proliferation. This could result in subsets
with differential growth rates. As an example, high oxygen ten-
sion in open tuberculosis cavities may boost local mycobacteria
growth in contrast to closed cavities (Barry et al., 2009; Via et al.,16 Cell Host & Microbe 17, January 14, 2015 ª2015 Elsevier Inc.2008). Indeed, early studies using resected lungs from tubercu-
losis patients found tremendously different delays inMycobacte-
rium outgrowth when culturing open versus closed cavities,
which might reflect in vivo growth characteristics (Vandiviere
et al., 1956). More recent studies found smaller mycobacteria
in cavities compared to sputum (Eum et al., 2010) that may indi-
cate slower growth, and substantial fractions of mycobacteria in
sputum contain lipid bodies (Garton et al., 2008), a potential
biomarker for nonreplicating cells. Another biomarker that can
be used to assess growth is ribosome content. Ribosome con-
tent and rRNA abundance closely correlate with bacterial growth
rate, and this can be exploited by direct rRNA detection using
in situ hybridization, or measuring transcriptional fusions to
rRNA promoters. Using these approaches, it was recently shown
that immunocompetent mice can partially control some myco-
bacterial subsets, resulting in a large diversity of (ex vivo) growth
rates (Manina et al., 2015). Similarly, Vibrio cholerae adhering to
intestinal epithelial cells have higher rRNA promoter activities
than the lumenal subpopulation, suggesting faster growth (Niel-
sen et al., 2010). Moreover, Pseudomonas aeruginosa cells in
sputum show a large range of growth rates based on their
rRNA content (Yang et al., 2008). As a potential caveat, rRNA
levels may not always strictly correlate with growth rate (Verma
et al., 1999). Another elegant approach utilizes a photo-switch-
able fluorescent protein that changes color from green to
red after excitation with high-intensity laser light (Mu¨ller et al.,
2013). Leishmania subsets with active metabolism and high pro-
tein turnover replace the photo-converted red protein with fresh
green protein more rapidly compared to quiescent subsets, and
this might be used as a surrogate for identifying actively growing
pathogen cells in vivo.
While these indirect approaches rely on pathogen activities
that likely correlate with growth, two recently developed
approaches directly determine pathogen in vivo growth at the
single-cell level. In the fluorescence dilution (FD) approach, path-
ogen cells are loaded with a fluorescent protein prior to infection.
With each cell division, this protein is distributed to the two
daughter cells, and fluorescence intensity per cell decreases to
half of the initial value. This approach revealed nonproliferating
Salmonella subsets in macrophages in vitro and mesenteric
lymph nodes of orally infected mice (Helaine et al., 2014). FD is
most useful to assess the first few divisions after infection, until
fluorescent protein dilution results in low signal-to-background
ratios. As a complementary method, the branched maturation
of the fluorescent TIMERprotein results in different green/orange
fluorescence ratios depending on division rate. This approach
is most suitable for tissues with homogeneous oxygen supply,
such as spleen red pulp. TIMER fluorescence revealed extensive
variation of Salmonella growth rates during systemic infection
(Claudi et al., 2014).
Taken together, the emerging evidence links distinct host
microenvironments with disparate outcomes of local host-path-
ogen interactions. Importantly, specific molecular interactions
such asRNS generation and detoxification, andROS-dependent
and -independent killing mechanisms, operate in separate mi-
croenvironments. As a consequence, perturbations of host and
pathogen factors selectively affect distinct local pathogen sub-
sets.Widely used bulk average readouts that disregard this strik-
ing heterogeneity might yield confusing results and controversial
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proaches (Burton et al., 2014).
Impact of Individual Outcomes on Overall Disease
Progression
Results for Salmonella and Mycobacterium clearly show that,
even if the host immune system is capable of successfully erad-
icating many infection foci, the host might still succumb to infec-
tion because some other pathogen subsets prevail (Meynell and
Stocker, 1957). Individual local failures, instead of a general inca-
pability of host control, are thus responsible for disease progres-
sion. It is of fundamental importance to understand why these
crucial local failures occur despite otherwise highly successful
host immunity, but underlying mechanisms still remain poorly
understood.
As an example, in both humans and monkeys, individual
mycobacteria infection foci are continuously eradicated, while
other lesions remain more static or even progress (Bobrowitz,
1980; Lin et al., 2013, 2014). Importantly, the main difference be-
tween controlled subclinical latent infection and open disease is
the appearance of open cavities with vigorously proliferatingmy-
cobacteria that gain direct access to the bronchial airways. Why
some foci progress into open cavities is one key question for pre-
venting active disease. As one speculative possibility, an initial
limited access to the bronchial systemmay increase oxygen ten-
sion within the cavity, thereby boosting mycobacteria growth,
inflammatory host responses, and increasing tissue damage
resulting in larger openings. Alternatively, some events might
trigger increased local inflammation, or mycobacterial prolifera-
tion, as primary events. A better understanding of underlying
cellular and molecular mechanisms could open opportunities
to identify patients with latent TB that are at high risk of devel-
oping active disease.
As another example, systemic salmonellosis primarily pro-
gresses by spreading Salmonella that continuously form new
infection foci (Sheppard et al., 2003), whereas old foci contribute
little, since locally accumulating neutrophils and inflammatory
monocytes successfully eradicate Salmonella (Burton et al.,
2014). A race between Salmonella dissemination and initial pro-
liferation at new foci and their detection and counteraction by the
host immune system thus determines the overall course of dis-
ease. Indeed, mice carrying functional alleles of Slc11a1, which
encodes the host resistance gene NRAMP1 that slows down
Salmonella intracellular growth (Claudi et al., 2014), can control
salmonellosis, although such mice still detect and attack only
some Salmonella subsets (Burton et al., 2014). Again, cellular
and molecular mechanisms governing the key steps of Salmo-
nella dissemination, foundation of new foci, and detection by
the host immune system remain incompletely characterized.
Pathogen Heterogeneity and Antimicrobial Treatment
Failures
Coexisting diverse pathogen subsets could have a major impact
on the efficacy of antimicrobial treatments. In particular, condi-
tions that lead to growth arrest of certain pathogen subsets
could promote high antimicrobial tolerance and treatment
failures (Balaban et al., 2013; Maisonneuve and Gerdes, 2014).
The main evidence for such pathogen heterogeneity under
clinically relevant conditions in patients are biphasic eradicationkinetics that are observed for many pathogens and diverse
antibiotics. Initially, pathogen tissue load drops rapidly, but sub-
sequently, further eradication slows down. The second slow
phase could be caused by pre-existing dormant pathogen sub-
sets that can tolerate extraordinary antimicrobial exposure
(‘‘persisters’’) as a result of phenotypic variation (as opposed
to inherited resistance). Such phenotypic pathogen subsets
can be generated under certain in vitro conditions such as
nutrient-starved stationary phase cultures, but they can also
spontaneously occur at low frequency in exponentially growing
cultures as a result of stochastic gene expression (Maisonneuve
and Gerdes, 2014).
However, biphasic eradication kinetics could also have
alternative explanations. This includes increasing pathogen
adaptation to antibiotic stress (Balaban et al., 2013), changes
in host microenvironments during treatment (Lin et al., 2013),
and differential drug delivery to distinct tissue microenviron-
ments. Furthermore, even if pre-existing pathogen heterogeneity
is involved, this could occur through growth-independent mech-
anisms such as differential expression of efflux pumps (Adams
et al., 2011) and pro-drug-converting enzymes (Wakamoto
et al., 2013) or asymmetric division (Aldridge et al., 2012).
This important issue is thus still unresolved, and in vivo data
for clinically relevant treatment conditions are scarce (Balaban
et al., 2013).
Recent data from mouse Salmonella infections, however,
clearly demonstrate a major impact of pre-existing in vivo
pathogen heterogeneity on treatment success. In particular,
nongrowing Salmonella subsets that occur earlier after oral
infection in mesenteric lymph nodes can persist for several
days during early-onset/high-dose antimicrobial chemotherapy
(Helaine et al., 2014; Kaiser et al., 2014). In a complementary
approach, Claudi et al. emulated clinically relevant conditions
by waiting until infected mice developed clear disease signs
and then starting chemotherapy with lower, clinically relevant
antibiotic doses (Claudi et al., 2014). Under these conditions,
treatment efficacy correlates with Salmonella single-cell division
rates at the onset of treatment. Surprisingly, most therapy survi-
vors originated from abundant, moderately growing Salmonella
subsets with partial antibiotic tolerance, while nongrowing
Salmonella were rare before and after treatment.
Conclusion and Outlook
Single-cell in vivo analyses show that pathogen subsets reside
in diverse host microenvironments in the same infected tissue.
Specific local conditions and pathogen responses result in indi-
vidual encounters with distinct molecular interactions and diver-
gent outcomes. These outcomes range from pathogen killing to
survival and growth at a large range of division rates. Importantly,
even hosts that rapidly succumb to infection can win individual
pathogen encounters and successfully eradicate many infection
foci. This demonstrates that fatal disease progression is not
necessarily the result of a generally weak host immune system,
but can rather be caused by failures at the individual lesion level.
Pathogen heterogeneity in infected host tissues can also have a
major impact on antimicrobial chemotherapy success. Together,
these findings demonstrate the previously unrecognized crucial
importance of heterogeneous host-pathogen interactions in
complex host tissues.Cell Host & Microbe 17, January 14, 2015 ª2015 Elsevier Inc. 17
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new field is still very fragmentary. In particular, only a few infec-
tious diseases have been studied using single-cell approaches,
although most infections likely involve diverse tissue microenvi-
ronments and disparate individual host-pathogen encounters.
Even for the better-characterized models, important pathogen
subsets have not yet been mapped to specific host microenvi-
ronments, and cellular and molecular mechanisms that deter-
mine the divergent outcomes of local encounters remain largely
uncharacterized. Moreover, most studies analyze discrete time
points, although the various encounters are highly dynamic.
Intravital video microscopy can offer fascinating insights, but
visualization of the critical processes that occur over many
hours/days remains challenging (Mu¨ller et al., 2013). Finally, indi-
vidual encounters, pathogen dissemination, formation of new
infection foci, as well as infiltration of immune cells and formation
of inflammatory lesions all occur in three-dimensional tissues.
These events thus require high-resolution analysis of mm-sized
areas in 3D, but current studies are mostly restricted to analysis
of essentially two-dimensional tissue regions or lack suitable
single-cell resolution. New technologies may help to overcome
some of these limitations.
The growing knowledge in this new field will provide funda-
mental insights in host-pathogen interactions and may make
important contributions to the development of new strategies
for control of infectious diseases. In particular, understanding
the key processes that lead to failures in host control of individual
lesions, and eventually to fatal disease, will provide a basis for
better prediction and control of such events. On the other
hand, detailed in vivo characterization of the distinct pathogen
subsets that are resilient against antimicrobial chemotherapy
might inspire development of targeted intervention strategies
that enable more effective and rapid treatment.
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